Thymidine kinase gene

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10610603
APP PUB NO 20180236101A1
SERIAL NO

15892295

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENVIVO INC475 HUNTINGTON DRIVE SAN MARINO CA 91108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johnson,, Jr Robert G Lafayette, US 11 18
Levy, John P Lake Elsinore, US 12 53
McNulty, Joseph Pasadena, US 7 18
Reed, Rebecca A Sherman Oaks, US 10 38

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 7, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 7, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00